These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10178625)

  • 1. Cataract, Alzheimer's disease, and other conformational diseases.
    Harding JJ
    Curr Opin Ophthalmol; 1998 Feb; 9(1):10-3. PubMed ID: 10178625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between Alzheimer disease and cataract].
    Liu SS; Zhu SQ
    Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):314-316. PubMed ID: 28412806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.
    Goldstein LE; Muffat JA; Cherny RA; Moir RD; Ericsson MH; Huang X; Mavros C; Coccia JA; Faget KY; Fitch KA; Masters CL; Tanzi RE; Chylack LT; Bush AI
    Lancet; 2003 Apr; 361(9365):1258-65. PubMed ID: 12699953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the cause of sporadic Alzheimer's disease.
    Zetterberg H; Mattsson N
    Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viewing molecular mechanisms of ageing through a lens.
    Harding JJ
    Ageing Res Rev; 2002 Jun; 1(3):465-79. PubMed ID: 12067598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of amyloid-beta in lenses of Alzheimer patients: a confocal Raman microspectroscopic study.
    Michael R; Otto C; Lenferink A; Gelpi E; Montenegro GA; Rosandić J; Tresserra F; Barraquer RI; Vrensen GF
    Exp Eye Res; 2014 Feb; 119():44-53. PubMed ID: 24333259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abeta conformational change is central to Alzheimer's disease.
    Holtzman DM
    Neurobiol Aging; 2002; 23(6):1085-8. PubMed ID: 12470806
    [No Abstract]   [Full Text] [Related]  

  • 9. Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer's Disease.
    Moosavi B; Mousavi B; Macreadie IG
    J Alzheimers Dis; 2015; 47(1):9-16. PubMed ID: 26402750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum.
    Jones DT; Graff-Radford J; Lowe VJ; Wiste HJ; Gunter JL; Senjem ML; Botha H; Kantarci K; Boeve BF; Knopman DS; Petersen RC; Jack CR
    Cortex; 2017 Dec; 97():143-159. PubMed ID: 29102243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Aβ42, τ-Protein, p16, p53 in Buccal Epithelium: Prospects for Use in the Diagnostics of Alzheimer's Disease and Rate of Aging.
    Zuev VA; Dyatlova AS; Lin'kova NS; Kvetnaya TV
    Bull Exp Biol Med; 2019 Mar; 166(5):676-679. PubMed ID: 30903490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins.
    Pavía J; de Ceballos ML; Sanchez de la Cuesta F
    Fundam Clin Pharmacol; 1998; 12(5):473-81. PubMed ID: 9794144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease.
    Selkoe DJ
    Neurobiol Aging; 1989; 10(5):387-95. PubMed ID: 2510035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.
    Yau WW; Tudorascu DL; McDade EM; Ikonomovic S; James JA; Minhas D; Mowrey W; Sheu LK; Snitz BE; Weissfeld L; Gianaros PJ; Aizenstein HJ; Price JC; Mathis CA; Lopez OL; Klunk WE
    Lancet Neurol; 2015 Aug; 14(8):804-813. PubMed ID: 26139022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?
    Smith MA; Drew KL; Nunomura A; Takeda A; Hirai K; Zhu X; Atwood CS; Raina AK; Rottkamp CA; Sayre LM; Friedland RP; Perry G
    Neurochem Int; 2002 May; 40(6):527-31. PubMed ID: 11850109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer's disease.
    Porzoor A; Macreadie IG
    J Alzheimers Dis; 2013; 35(2):217-25. PubMed ID: 23396350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
    Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
    Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the difference between PART and Alzheimer's disease lie in the age-related changes in cerebral arteries that trigger the accumulation of Aβ and propagation of tau?
    Weller RO; Hawkes CA; Carare RO; Hardy J
    Acta Neuropathol; 2015 May; 129(5):763-6. PubMed ID: 25814152
    [No Abstract]   [Full Text] [Related]  

  • 20. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
    Shin J
    Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.